Anthony S. Don

3.9k total citations
73 papers, 2.8k citations indexed

About

Anthony S. Don is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Anthony S. Don has authored 73 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 17 papers in Physiology and 12 papers in Cell Biology. Recurrent topics in Anthony S. Don's work include Sphingolipid Metabolism and Signaling (42 papers), Lipid Membrane Structure and Behavior (16 papers) and Endoplasmic Reticulum Stress and Disease (11 papers). Anthony S. Don is often cited by papers focused on Sphingolipid Metabolism and Signaling (42 papers), Lipid Membrane Structure and Behavior (16 papers) and Endoplasmic Reticulum Stress and Disease (11 papers). Anthony S. Don collaborates with scholars based in Australia, United States and China. Anthony S. Don's co-authors include Philip J. Hogg, Hugh Rosen, Timothy A. Couttas, Nupur Kain, David Marsolais, Pedro J. Gonzalez‐Cabrera, Marta Sanna, Xin Ying Lim, Brett Garner and Sheng‐Kai Wang and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Anthony S. Don

70 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony S. Don Australia 29 2.0k 592 479 310 296 73 2.8k
Jianhai Du United States 36 2.4k 1.2× 472 0.8× 229 0.5× 390 1.3× 171 0.6× 95 3.3k
Hideru Obinata Japan 21 1.8k 0.9× 432 0.7× 476 1.0× 193 0.6× 379 1.3× 53 2.7k
Caoimhín G. Concannon Ireland 29 2.1k 1.0× 372 0.6× 536 1.1× 345 1.1× 195 0.7× 48 2.9k
Leah J. Siskind United States 31 2.5k 1.2× 430 0.7× 436 0.9× 175 0.6× 293 1.0× 63 3.3k
Haipeng Cheng China 27 1.3k 0.7× 688 1.2× 395 0.8× 350 1.1× 185 0.6× 71 2.3k
Richard Kolesnick United States 21 1.9k 0.9× 341 0.6× 296 0.6× 227 0.7× 337 1.1× 44 2.7k
Grisha Pirianov United Kingdom 23 2.1k 1.0× 317 0.5× 615 1.3× 227 0.7× 506 1.7× 39 3.2k
Valentina Bonetto Italy 31 2.2k 1.1× 501 0.8× 385 0.8× 199 0.6× 247 0.8× 72 3.4k
Antonio Feliciello Italy 37 2.4k 1.2× 351 0.6× 305 0.6× 278 0.9× 219 0.7× 67 3.5k
Joo‐Ho Shin South Korea 26 2.1k 1.0× 666 1.1× 386 0.8× 193 0.6× 186 0.6× 74 3.7k

Countries citing papers authored by Anthony S. Don

Since Specialization
Citations

This map shows the geographic impact of Anthony S. Don's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony S. Don with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony S. Don more than expected).

Fields of papers citing papers by Anthony S. Don

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony S. Don. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony S. Don. The network helps show where Anthony S. Don may publish in the future.

Co-authorship network of co-authors of Anthony S. Don

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony S. Don. A scholar is included among the top collaborators of Anthony S. Don based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony S. Don. Anthony S. Don is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghezzi, Laura, Georgia Watt, Dana C. Perantie, et al.. (2025). The Serum Lipid Profile of Relapsing Multiple Sclerosis Differs Reproducibly From Healthy Controls. Journal of Neurochemistry. 169(11). e70285–e70285.
2.
Zhang, Yunwei, Dylan Harney, Holly P. McEwen, et al.. (2025). Left ventricular myocardial molecular profile of human diabetic ischaemic cardiomyopathy. EMBO Molecular Medicine. 17(9). 2483–2524. 1 indexed citations
3.
Madsen, Søren, Kristen C. Cooke, Christoph Rau, et al.. (2025). Muscle very long-chain ceramides associate with insulin resistance independently of obesity. Molecular Metabolism. 99. 102212–102212.
4.
Andersen, Jens V., Emil W. Westi, Blanca I. Aldana, et al.. (2024). Deficient brain GABA metabolism leads to widespread impairments of astrocyte and oligodendrocyte function. Glia. 72(10). 1821–1839. 2 indexed citations
5.
Ghezzi, Laura, Chiara Fenoglio, Anna M. Pietroboni, et al.. (2024). CSF sphingolipids are correlated with neuroinflammatory cytokines and differentiate neuromyelitis optica spectrum disorder from multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 96(1). 54–67. 3 indexed citations
6.
Díaz‐Vegas, Alexis, Søren Madsen, Kristen C. Cooke, et al.. (2023). Mitochondrial electron transport chain, ceramide, and coenzyme Q are linked in a pathway that drives insulin resistance in skeletal muscle. eLife. 12. 17 indexed citations
7.
Díaz‐Vegas, Alexis, Søren Madsen, Kristen C. Cooke, et al.. (2023). Mitochondrial electron transport chain, ceramide, and coenzyme Q are linked in a pathway that drives insulin resistance in skeletal muscle. eLife. 12. 23 indexed citations
8.
Lee, Jun Yup, Dylan Harney, Jonathan D. Teo, et al.. (2023). The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus. Molecular Neurodegeneration. 18(1). 63–63. 19 indexed citations
9.
Teo, Jonathan D., Alanna G. Spiteri, Holly P. McEwen, et al.. (2022). Early microglial response, myelin deterioration and lethality in mice deficient for very long chain ceramide synthesis in oligodendrocytes. Glia. 71(4). 1120–1141. 20 indexed citations
10.
Montgomery, Magdalene K., Jacqueline Bayliss, Shuai Nie, et al.. (2022). Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control. Nature Communications. 13(1). 1259–1259. 22 indexed citations
11.
Liu, Da, Jinbiao Chen, Yu Huang, et al.. (2022). Ablation of sphingosine kinase 2 suppresses fatty liver-associated hepatocellular carcinoma via downregulation of ceramide transfer protein. Oncogenesis. 11(1). 67–67. 18 indexed citations
12.
Wang, Yi-Chang, Ximing Du, Hoi Yin Mak, et al.. (2021). TMEM41B and VMP1 are scramblases and regulate the distribution of cholesterol and phosphatidylserine. The Journal of Cell Biology. 220(6). 119 indexed citations
13.
Sheedy, Donna, et al.. (2021). Lipidome changes in alcohol‐related brain damage. Journal of Neurochemistry. 160(2). 271–282. 6 indexed citations
14.
Couttas, Timothy A., et al.. (2017). Contextual fear conditioning is enhanced in mice lacking functional sphingosine kinase 2. Behavioural Brain Research. 333. 9–16. 11 indexed citations
15.
Couttas, Timothy A., Nupur Kain, Alexandra K. Suchowerska, et al.. (2016). Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer's disease. Neurobiology of Aging. 43. 89–100. 69 indexed citations
16.
Chen, Jinbiao, Wei Wang, Yanfei Qi, et al.. (2015). Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(2). 138–147. 44 indexed citations
17.
Couttas, Timothy A. & Anthony S. Don. (2015). Fluorescent Assays for Ceramide Synthase Activity. Methods in molecular biology. 1376. 23–33. 1 indexed citations
18.
Collison, Adam, Luke Hatchwell, Nicole M. Verrills, et al.. (2013). The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nature Medicine. 19(2). 232–237. 126 indexed citations
19.
Jary, Eve, Thomas Bee, Scott R. Walker, et al.. (2010). Elimination of a Hydroxyl Group in FTY720 Dramatically Improves the Phosphorylation Rate. Molecular Pharmacology. 78(4). 685–692. 13 indexed citations
20.
Dilda, Pierre J., Anthony S. Don, Vincent J. Higgins, et al.. (2005). Mechanism of Selectivity of an Angiogenesis Inhibitor From Screening a Genome-Wide Set of Saccharomyces cerevisiae Deletion Strains. JNCI Journal of the National Cancer Institute. 97(20). 1539–1547. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026